DealParabilis Medicines, a Cambridge, MA-based biotech company advancing clinical development of its lead candidate, raised $305 million in a Series F fundraising round co-led by RA Capital Management, Fidelity Management & Research Company, and Janus Henderson Investors.
More on STAT+ →
OTHER
01/12/2026
Verismo Therapeutics, Inc., a Philadelphia, PA-based CAR-T cell therapy...
Yoga Joint, a Fort Lauderdale, FL-based hot yoga studio chain, raised $5.5...
Timeshifter, a New York-based circadian tech for jet lag, raised an...
Osteoboost Health, a Redwood City, CA-based FDA-cleared bone health...
Clean Slate Clinic, a Sydney-based virtual alcohol detox platform, raised...
Reme-D, a Cairo-based room-temperature PCR test kits company, raised...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
